7571 - 7580 of 8620 Results
Title
Year
-
OPENTitle: Genetic Modifiers of Parkinson's Disease: A Case–Control StudyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/acn3.70176Citation Count: 0
- Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features2017OPENTitle: Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease FeaturesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 282End Page: 288Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27232Best OA location URL: https://escholarship.org/content/qt7gp9f6h5/qt7gp9f6h5.pdfCitation Count: 138
- Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental Approach2024OPENTitle: Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental ApproachJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 26Issue #: 1Start Page: 9End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms26010009Best OA location URL: https://www.mdpi.com/1422-0067/26/1/9/pdf?version=1735026493Citation Count: 4
- Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetin2013RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 80
- Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice2020OPENTitle: Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic MiceJournal Name: Molecular Therapy Nucleic AcidsPublisher: Elsevier BVVol: 21Issue #:Start Page: 623End Page: 635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.omtn.2020.06.027Best OA location URL: http://www.cell.com/article/S2162253120301888/pdfCitation Count: 37
- Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations2024OPENTitle: Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populationsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 10Start Page: 7174End Page: 7192Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14208Best OA location URL: https://escholarship.org/content/qt9ph632vx/qt9ph632vx.pdfCitation Count: 8
- Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease2016RESTRICTEDTitle: Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 113Issue #:Start Page: 110End Page: 123Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.09.028Citation Count: 57
-
OPENTitle: An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During AgingJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.721749Best OA location URL: https://doi.org/10.3389/fnmol.2021.721749Citation Count: 13
- Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity2022OPENTitle: Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00388-7Best OA location URL: https://www.nature.com/articles/s41531-022-00388-7.pdfCitation Count: 42
- Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease2019OPENTitle: Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 6Start Page: e0217566End Page: e0217566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0217566Citation Count: 49